METHOD OF PURIFYING FILAMENTOUS BACTERIOPHAGE M13 Russian patent published in 2017 - IPC C12N7/02 

Abstract RU 2610178 C1

FIELD: biotechnology.

SUBSTANCE: invention relates to a method of purifying filamentous bacteriophage M13. Method involves removal of bacterial mass after producing bacteriophage by first and second successive centrifugation followed by first purification of supernatant of bacteriophage by isoelectric precipitation with a reagent at pH 4.2, further third centrifuging and re-suspension of precipitate with bacteriophage, as well as repeated purification of suspension of bacteriophage by isoelectric precipitation with a reagent at pH 4.2 and fourth centrifugation of precipitate with bacteriophage to produce end product. For isoelectric precipitation agent used is sodium acetate buffer with pH = 4.2 in ratio to supernatant of bacteriophages of not less than 3:1 at first isoelectric precipitation, precipitate with bacteriophage after third centrifugation is re-suspended in TBS-buffer, and during repeated purification of re-suspended bacteriophage by isoelectric precipitation, sodium acetate buffer with pH = 4.2 is used in ratio to re-suspended bacteriophage of not less than 1:1. First and second centrifugation is carried out at 5,000 rpm and 12,000 rpm for 10 minutes at 20 °C, and third and fourth centrifugation is carried out at 10,000 rpm for 10 minutes at 4 °C.

EFFECT: invention provides a higher level of sterility and purity of bacteriophage, especially in small quantities thereof using a simpler technique.

1 cl, 7 tbl, 9 ex

Similar patents RU2610178C1

Title Year Author Number
COMBINATORIAL FRAGMID LIBRARY OF HUMAN SINGLE-STRANDED ANTIBODIES ENRICHED WITH ANTIBODIES AGAINST VARIOLOVACCINE VIRUS, RECOMBINANT FRAGMID pHEN-2A8 DNA CONTAINING UNIQUE GENE OF HUMAN SINGLE-STRANDED ANTIBODY, CAPABLE OF NEUTRALIZING VARIOLOVACCINE VIRUS AND COWPOX VIRUS, AND ARTIFICIAL HUMAN SINGLE-STRANDED 2A8 ANTIBODY CAPABLE OF NEUTRALIZING VARIOLOVACCINE VIRUS AND COWPOX VIRUS 2005
  • Dubrovskaja Viktorija Vladislavovna
  • Tikunova Nina Viktorovna
  • Morozova Vera Vital'Evna
  • Bormotov Nikolaj Ivanovich
  • Laman Aleksandr Georgievich
  • Ulitin Andrej Borisovich
  • Brovko Fedor Aleksandrovich
  • Belanov Evgenij Fedorovich
  • Il'Ichev Aleksandr Alekseevich
RU2311927C2
RECOMBINANT PHAGE DNA M13 POL T7 AND RECOMBINANT STRAIN OF PHAGE M13 - A PRODUCER OF PHAGE T7 RNA-POLYMERASE 1994
  • Il'Ichev A.A.
  • Melamed N.V.
  • Dolgova I.N.
  • Khomov V.V.
  • Sizov A.A.
  • Petrenko V.A.
RU2089613C1
METHOD FOR PRODUCING CELL SURFACE PROTEINS 2017
  • Selivanov Nikolaj Yurevich
  • Selivanova Olga Gennadevna
  • Galitskaya Anna Alekseevna
  • Sokolov Oleg Igorevich
RU2670001C1
AGENT FOR NEUTRALISING SMALLPOX VIRUS 2013
  • Khlusevich Jana Aleksandrovna
  • Tikunova Nina Viktorovna
  • Morozova Vera Vital'Evna
  • Bulychev Leonid Egorovich
  • Bormotov Nikolaj Ivanovich
  • Vlasov Valentin Viktorovich
  • Sergeev Aleksandr Nikolaevich
RU2515905C1
RECOMBINANT FRAGMID DNA pHEN-TAB CONTAINING HUMAN SINGLE-STRAND ANTIBODY GENE, CAPABLE OF BINDING OF HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT Escherichia coli BACTERIA STRAIN AS PRODUCER OF HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT SOLUBLE HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA 2005
  • Batanova Tat'Jana Aleksandrovna
  • Tikunova Nina Viktorovna
  • Jun Tat'Jana Ehverestovna
RU2307163C2
HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS 2014
  • Pironti Vincenza
  • Becker Robert
  • Boltri Luigi
  • Ghidorsi Luigi
  • Arzuffi Paola
RU2686460C2
TUMOUR-SPECIFIC PEPTIDE FOR ADDRESS CHEMOTHERAPY OF HUMAN BREAST CANCER 2015
  • Vaskova Anna Andreevna
  • Kuligina Elena Vladimirovna
  • Makartsova Anna Aleksandrovna
  • Koval Olga Aleksandrovna
  • Rikhter Vladimir Aleksandrovich
RU2595404C1
CONSTRUCTION OF MODIFIED FILAMENTOUS BACTERIOPHAGE FOR TREATMENT OR PROPHYLAXIS OF BACTERIAL INFECTION, MODIFIED BACTERIOPHAGE M14, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF BACTERIAL INFECTION, MONOCLONAL ANTIBODY, HYBRIDOMA (VARIANT) 1997
  • Mardkh Sven
RU2215032C2
PLASMID FOR EXPRESSION IN CELLS OF BACTERIUM BELONGING TO Escherichia CLASS, NON-ACTIVE PREDECESSOR OF DNase I OF HUMAN OR ITS MUTEINS; BACTERIUM BELONGING TO Escherichia CLASS, - PRODUCER OF NON-ACTIVE PREDECESSOR OF RECOMBINANT DNase I OF HUMAN OR ITS MUTEIN; PREDECESSOR OF RECOMBINANT DNase I OF HUMAN OR ITS MUTEIN; METHOD FOR OBTAINING RECOMBINANT DNase I OF HUMAN OR ITS MUTEIN; METHOD FOR OBTAINING CONJUGATES OF POLYETHYLENE GLYCOL AND RECOMBINANT MUTEIN OF HUMAN DNase I, FERMENTATIVE ACTIVE CONJUGATE OF MUTEIN OF RECOMBINANT DNase I OF HUMAN 2011
  • Orlova Nadezhda Aleksandrovna
  • Vorob'Ev Ivan Ivanovich
RU2502803C2
EXPRESSION PLASMID DNA p6E-tTF CODING EXTRACELLULAR AND TRANSMEMBRANE DOMAINS OF HUMAN TISSUE FACTOR AND E.coli BL21 [DE3]/p6E-tTF STRAIN - PRODUCER OF RECOMBINANT HUMAN TISSUE FACTOR 2008
  • Orlova Nadezhda Aleksandrovna
  • Vorob'Ev Ivan Ivanovich
RU2426780C2

RU 2 610 178 C1

Authors

Ivanova Kseniya Anatolevna

Volkova Natalya Vyacheslavovna

Shcherbakov Dmitrij Nikolaevich

Ilichev Aleksandr Alekseevich

Dates

2017-02-08Published

2015-10-15Filed